Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenergic agents: clinical trials and experiences.

L Hansson1

  • 1Department of Medicine, Ostra Hospital, University of Göteborg, Sweden.

Cleveland Clinic Journal of Medicine
|May 1, 1992
PubMed
Summary

Beta blockers are a common hypertension treatment, but their cardioprotective benefits remain unproven. Animal studies suggest an antiatherosclerotic effect, warranting further clinical investigation for potential future therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-adrenergic blocking agents are widely used for hypertension management globally.
  • Extensive clinical trials have been conducted, but definitive cardioprotective effects are not yet established.

Purpose of the Study:

  • To evaluate the established and potential therapeutic effects of beta blockers beyond blood pressure control.
  • To assess the antiatherosclerotic potential and impact on left ventricular hypertrophy.

Main Methods:

  • Review of comparative trials and animal experiments on beta blockers.
  • Analysis of evidence regarding antiatherosclerotic and regression of left ventricular hypertrophy effects.

Main Results:

  • The cardioprotective effect of beta blockers requires further confirmation in clinical settings.
  • Animal studies indicate a potential antiatherosclerotic effect of beta blockers.
  • Beta blockers can reverse hypertension-induced left ventricular hypertrophy, but clinical risk reduction is unproven.

Conclusions:

  • While beta blockers are first-line hypertension therapy, their cardioprotective role needs more evidence.
  • Emerging evidence suggests potential antiatherosclerotic and left ventricular hypertrophy regression benefits that require clinical validation.

Related Experiment Videos